HITV Lab

Call Us : +603-9010-3058
Email Us : This email address is being protected from spambots. You need JavaScript enabled to view it.

Home Publications, News & Events

Tuesday22 August 2017

南洋网 : 癌症治疗 曙光再现

nanyang

人类对抗癌症的征途遥远而艰辛,每一次新疗法出现,都如同一道曙光,带来希望。

近年来被广泛用于癌症治疗的免疫疗法不断推陈出新,这一次,从日本传来了好消息……

自我免疫力抗癌细胞 癌症临床新疗法

莲见贤一郎医生(Dr.Kenichiro Hasumi)在8年前发现了人类自愈疫苗疗法(Human Initiated Therapeutic Vaccine,简称HITV),为末期癌症患者带来了希望。

人类自愈疫苗疗法是一项以免疫学作为基础的癌症疗法,主要针对那些癌症治疗失败后的末期癌症患者。

加强细胞免疫力

 

Read more ...

HITV Lab

HITV Lab is involved in cell-based biotechnology medical applications with special focus on Dendritic Cell-Based Immunotherapy for cancer. HITV Lab is committed to support an international collaboration in the FDA clinical trial of HITV Therapy in late-stage cancer patients led by the University of Maryland, USA.

FacebookTwitterGoogle Bookmarks